Jairo Aldana-Bitar, Ilana S Golub, Jeff Moore, Srikanth Krishnan, Dhiran Verghese, Venkat S Manubolu, Travis Benzing, Keshi Ichikawa, Sajad Hamal, Sina Kianoush, Lauren R Anderson, Noah R Ramirez, Jonathon A Leipsic, Ronald P Karlsberg, Matthew J Budoff
Colchicine is an anti-inflammatory medication, classically used to treat a wide spectrum of autoimmune diseases. More recently, colchicine has proven itself a key pharmacotherapy in cardiovascular disease (CVD) management, atherosclerotic plaque modification, and coronary artery disease (CAD) treatment. Colchicine acts on many anti-inflammatory pathways, which translates to cardiovascular event reduction, plaque transformation, and plaque reduction. With the FDA's 2023 approval of colchicine for reducing cardiovascular events, a novel clinical pathway opens...
February 27, 2024: Progress in Cardiovascular Diseases